U.S. market Closed. Opens in 2 days 1 hour 58 minutes

EW | Edwards Lifesciences Corporation Stock Financials Income Statements Annual

(Stock Exchange: NYSE)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue6.00B5.38B5.23B4.39B4.35B3.72B3.44B2.96B2.49B2.32B2.05B1.90B1.68B1.45B1.32B1.24B1.09B1.04B997.90M931.50M860.50M704.00M692.00M804.00M905.00M
Cost of Revenue1.38B1.08B1.25B1.08B1.11B939.40M875.30M797.40M617.20M625.60M522.40M494.60M489.80M408.30M399.10M419.60M378.20M373.60M374.60M370.20M359.40M299.10M324.00M423.00M466.00M
Gross Profit4.62B4.30B3.98B3.31B3.23B2.78B2.56B2.17B1.88B1.70B1.52B1.41B1.19B1.04B922.30M818.10M712.90M663.40M623.30M561.30M501.10M404.90M368.00M381.00M439.00M
Operating Expenses2.90B2.51B2.40B1.99B1.99B1.71B1.54B1.38B1.23B1.21B1.07B996.60M888.70M754.40M684.30M619.80M540.30M490.20M447.70M406.90M362.70M352.80M344.00M286.00M322.00M
Selling, General & Admin1.82B1.57B1.49B1.23B1.24B1.09B984.70M904.70M850.70M858.00M745.60M705.30M642.40M550.00M508.80M480.60M418.00M376.00M348.70M319.90M289.90M227.90M203.00M216.00M233.00M
Research & Development1.07B945.20M903.10M760.70M752.70M622.20M552.60M477.80M383.10M356.70M323.00M291.30M246.30M204.40M175.50M139.20M122.30M114.20M99.00M87.00M72.80M65.20M55.00M55.00M55.00M
Other Operating Expenses3.40M2.60M12.70M11.50M8.20M4.00MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A59.70M86.00M15.00M34.00M
Operating Income1.53B1.75B1.35B1.63B1.15B748.20M1.02B783.80M642.70M482.60M454.50M408.40M300.10M284.30M238.00M198.30M172.60M173.20M175.60M154.40M138.40M52.10M24.00M95.00M117.00M
Other Expenses / Income-181.30M18.90M353.50M-711.70M19.70M-313.40M12.20M-45.90M-20.30M661.40M60.80M-17.30M-16.50M-16.10M66.40M-33.90M-22.80M-900.00K-58.90M-124.30M-45.60M3.90M-33.00M-354.00M-4.00M
Before Tax Income1.60B1.77B1.70B916.70M1.17B761.40M1.03B737.90M622.40M1.14B515.30M391.10M283.60M268.20M304.40M164.40M149.80M172.30M116.70M30.10M92.80M56.00M-9.00M-259.00M113.00M
Income Tax Expenses198.70M245.50M198.90M93.30M119.60M39.20M451.30M168.40M127.50M332.90M123.60M97.90M46.90M50.20M75.30M35.50M36.80M41.80M37.40M28.40M13.80M300.00K1.00M13.00M31.00M
Net Income1.40B1.52B1.50B823.40M1.05B722.20M583.60M569.50M494.90M811.10M391.70M293.20M236.70M218.00M229.10M128.90M113.00M130.50M79.30M1.70M79.00M55.70M-12.00M-272.00M82.00M
Interest Expenses17.60M19.20M18.40M15.80M20.70M-2.10M23.20M19.20M17.20M17.20M9.80M4.40M3.10M2.40M2.70M7.20MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding606.70M619.00M623.30M622.60M624.90M627.60M632.70M639.00M646.50M639.00M670.20M689.40M687.60M682.20M675.60M669.60M687.60M702.00M715.20M715.20M709.20M708.00M708.00M700.80M697.07M
Diluted Shares Outstanding609.40M624.20M631.20M631.90M636.60M640.80M647.70M653.40M660.90M651.00M682.80M709.80M716.40M715.20M704.40M715.20M752.40M766.80M747.60M744.00M733.20M735.60M708.00M700.80M697.07M
EBITDA1.95B1.83B1.48B1.74B1.33B1.39B1.14B828.30M705.40M1.23B593.80M452.80M344.70M327.10M365.80M227.20M204.60M229.10M172.90M85.80M138.40M96.40M46.00M-185.00M197.00M
EBITDA Margin32.40%34.00%28.35%39.57%30.60%37.34%33.18%27.95%28.29%52.94%29.03%23.84%20.53%22.61%27.68%18.36%18.75%22.09%17.33%9.21%16.08%13.69%6.65%-23.01%21.77%
EBIT1.62B1.79B1.72B932.50M1.19B759.30M1.06B757.10M639.60M1.16B525.10M395.50M286.70M270.60M307.10M171.60M149.80M172.30M116.70M30.10M92.80M56.00M-11.00M-259.00M113.00M
EBIT Margin26.96%33.19%32.88%21.26%27.30%20.40%30.80%25.55%25.65%49.99%25.67%20.82%17.08%18.70%23.24%13.86%13.73%16.62%11.69%3.23%10.78%7.95%-1.59%-32.21%12.49%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙